Showing results (1561-1570 of 1,687) with videos related to

Sort By:
Pageof 169
Chemico-Biological Interactions|February 15, 2026
Inhibiting NAT10 suppresses hepatocellular carcinoma progression by reducing Nrf2 mRNA stability and increasing oxidative stressWei Gu, Ziyi Ren, Jie Gao, et al.
Cell Death & Disease|September 22, 2018
p53 cooperates with SIRT6 to regulate cardiolipin de novo biosynthesisMeiting Li, Tianyun Hou, Tian Gao, et al.
Standards in Genomic Sciences|July 1, 2014
Genome sequence of the clover-nodulating Rhizobium leguminosarum bv. trifolii strain SRDI943Wayne Reeve, Elizabeth Drew, Ross Ballard, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 22, 2010
Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptorWei Gu, Katherine A Winters, Alykhan S Motani, et al.
ACS Omega|May 31, 2021
Synthesis and Anti-Pancreatic Cancer Activity Studies of Novel 3-Amino-2-hydroxybenzofused 2-Phospha-γ-lactonesSatheesh Krishna Balam, Jayaprakash Soora Harinath, Suresh Kumar Krishnammagari, et al.
Nature Cancer|March 27, 2023
Specific regulation of BACH1 by the hotspot mutant p53R175H reveals a distinct gain-of-function mechanismZhenyi Su, Ning Kon, Jingjie Yi, et al.
Aging|August 11, 2019
LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axisEr-Lin Song, Li Xing, Liang Wang, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Inactive Parp2 causes Tp53-dependent lethal anemia by blocking replication-associated nick ligation in erythroblastsXiaohui Lin, Dipika Gupta, Alina Vaitsiankova, et al.
General Psychiatry|December 22, 2025
Efficacy and safety of GW117 tablets in major depressive disorder: a randomised, double-blind, placebo-controlled, phase 2 dose-finding studyYifeng Shen, Xiaonan Hao, Xiaoning Shi, et al.
Chinese Medical Journal|May 13, 2015
Efficacy and safety of avandamet or uptitrated metformin treatment in patients with type 2 diabetes inadequately controlled with metformin alone: a multicenter, randomized, controlled trialXiao-Ling Cai, Ying-Li Chen, Jia-Jun Zhao, et al.
Pageof 169